Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection (Q42278604)

19 October 2017

Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection (English)

1 reference

19 October 2017

0 references

4

Annette Oxenius

1 reference

19 October 2017

Sanja Mandaric Jeitziner

series ordinal

1

1 reference

19 October 2017

Senta M Walton

series ordinal

2

1 reference

19 October 2017

Nicole Torti

series ordinal

3

1 reference

19 October 2017

language of work or name

English

0 references

publication date

26 August 2013

1 reference

European Journal of Immunology

19 October 2017

1 reference

19 October 2017

43

1 reference

19 October 2017

11

1 reference

19 October 2017

2886-2895

1 reference

An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection

19 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Protective Role of Fas-FasL Signaling in Lethal Infection with Herpes Simplex Virus Type 2 in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Pathogenesis of murine cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Immunobiology of human cytomegalovirus: from bench to bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Properties of CD4(+) T cells in human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

How chronic viral infections impact on antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Role of PD-1 in regulating acute infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Spectrum of Epstein-Barr virus-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

Expanding roles for CD4⁺ T cells in immunity to viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

A mouse model for cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Induction and protective role of antibodies in Legionella pneumophila infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343690

7 January 2021

Identifiers

DOI

10.1002/EJI.201343690

1 reference

19 October 2017

1 reference